Invesco Ltd. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$784,809
-14.8%
249,939
+40.0%
0.00%
Q2 2023$921,313
+3.4%
178,549
+5.6%
0.00%
Q1 2023$891,431
+19.4%
169,152
-36.4%
0.00%
Q4 2022$746,822
+32.4%
265,773
+95.4%
0.00%
Q3 2022$564,000
-18.8%
135,985
-21.4%
0.00%
Q2 2022$695,000
-12.5%
172,943
+7.9%
0.00%
Q1 2022$794,000
-16.9%
160,324
+16.9%
0.00%
Q4 2021$955,000
-10.2%
137,099
+28.8%
0.00%
Q3 2021$1,064,000
-15.2%
106,441
+20.2%
0.00%
Q2 2021$1,255,000
+22.6%
88,518
+41.9%
0.00%
Q1 2021$1,024,000
-95.1%
62,372
-93.8%
0.00%
-100.0%
Q4 2020$20,718,000
+1333.8%
1,000,896
+427.2%
0.01%
Q3 2020$1,445,000
-71.2%
189,841
-68.5%
0.00%
-100.0%
Q2 2020$5,020,000
+629.7%
602,673
+333.6%
0.00%
Q1 2020$688,000
-39.4%
138,979
-51.4%
0.00%
Q1 2019$1,136,000
+31.2%
286,118
+31.5%
0.00%
Q4 2018$866,000
+257.9%
217,648
+519.4%
0.00%
Q3 2018$242,000
+36.7%
35,138
+34.2%
0.00%
Q2 2018$177,000
+205.2%
26,183
+846.3%
0.00%
Q2 2015$58,0002,7670.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders